Skip to content

Clinical trials

Observational Asthma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Observational Clear all

1,254 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200014
200111
20027
200310
200421
200530
200627
200761
200840
200960
201043
201158
201249
201334
201428
201549
201646
201760
201850
201958
202062
202180
202261
202362
202471
202553
202635

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed778
Unknown status203
Recruiting112
Terminated44
Active, not recruiting35
Not yet recruiting35
Withdrawn31
Enrolling by invitation12
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca98
National Heart, Lung, and Blood Institute (NHLBI)58
GlaxoSmithKline24
National Institute of Environmental Health Sciences (NIEHS)24
National Institute of Allergy and Infectious Diseases (NIAID)22
University of California, San Francisco18
Imperial College London16
Assistance Publique - Hôpitaux de Paris15
Brigham and Women's Hospital15
Research in Real-Life Ltd15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma1,254
Pulmonary Disease, Chronic Obstructive199
Lung Diseases77
Hypersensitivity75
Rhinitis, Allergic44
Disease35
Obesity34
Heart Failure32
Diabetes Mellitus29
Respiratory Sounds29

Trials

Showing 51 to 75 of 1,254. Each trial links to its page on Pharma Observatory.

1,154 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.